Navigation Links
UC Irvine to lead statewide program on green materials research
Date:6/2/2008

Irvine, Calif., June 2, 2008 UC Irvine has been awarded $1.62 million to lead a University of California program on development of nontoxic alternatives to everyday products, such as electronics, plastics, lighting products, fuels and pesticides.

UCI has been designated the Lead Campus for a Green Materials Program, which will foster research and graduate-level training at UC campuses. Oladele Ogunseitan, professor of public health and social ecology at UCI and international expert on environmental health sciences, will serve as inaugural director.

"There is a great need to develop new, nontoxic alternatives for the commercial products we regularly use," said Ogunseitan, whose research seeks to mitigate environmental pollutants that contribute to human disease and ecosystem degradation. "This program will have great impact on the people of California, because it will draw upon our expertise in these areas and employ it for the health and benefit of society."

The Green Materials Program at UCI will bring together public health, toxicology, materials science, engineering and social science experts to work on innovative approaches to reducing health and environmental hazards associated with materials use in society.

Priority topics to be tackled include:

  • Brominated flame retardants that have recently been detected in alarming levels in California peregrine falcons
  • Mercury content of energy-saving compact fluorescent lamps
  • Phthalate plasticizers, linked to liver damage and fertility problems, found in food containers and toys.

Researchers also will seek to coordinate activities with the state-funded California Environmental Contaminants Biomonitoring Program to quickly identify and respond to trends in the variety of chemicals detected in the population.

Participants will study California policies within the context of emerging international initiatives such
'/>"/>

Contact: Tom Vasich
tmvasich@uci.edu
949-824-6455
University of California - Irvine
Source:Eurekalert

Page: 1 2

Related medicine news :

1. UC-Irvine scientists present groundbreaking research at Society for Neuroscience conference
2. UC Irvine researchers present latest findings at emergency medicine forum
3. New Jersey Physicians Launch New, Statewide Association to Fight for Stronger Voice in Healthcare
4. The Cooper Institutes FITNESSGRAM Selected as Statewide Physical Fitness Assessment Tool
5. Governor Rendell to Fight to Cover All Pennsylvanians During Statewide Bus Tour
6. UPDATE: Governor Rendell to Fight to Cover All Pennsylvanians During Statewide Bus Tour
7. Minneapolis Hosts National Conference on Tobacco or Health October 24-26 on Heels of Minnesotas Statewide, Smoke-Free Law
8. Tenet Hospital Workers Ratify Statewide Contract
9. RACE: a statewide model of better, faster heart attack care
10. Statewide program helps improve quality of care for heart attack
11. Statewide Meetings Will Help Pennsylvanians to Choose Among Medicare Prescription Plans
Post Your Comments:
*Name:
*Comment:
*Email:
Other Medicine News:Health News:Phoenix Health Systems and SunGard Availability Services Partner to Deliver Data and IT Management Solutions to Community Hospitals 2Health News:Phoenix Health Systems and SunGard Availability Services Partner to Deliver Data and IT Management Solutions to Community Hospitals 3Health News:Plaques, Tangles in Brain Don't Always Lead to Alzheimer's 2Health News:UNICEF Appeals for Funding to Urgently Assist Displaced Children and Women in Northwest Pakistan 2Health News:Minnesota Vikings, Hunger Solutions Minnesota and Second Harvest Heartland to Help Secure 200,000 Meals for Hungry Minnesota Children This Summer 2Health News:Minnesota Vikings, Hunger Solutions Minnesota and Second Harvest Heartland to Help Secure 200,000 Meals for Hungry Minnesota Children This Summer 3Health News:Minnesota Vikings, Hunger Solutions Minnesota and Second Harvest Heartland to Help Secure 200,000 Meals for Hungry Minnesota Children This Summer 4Health News:Deadline Extended for Nominations for Jay and Rose Phillips Awards and Phillips Caregiver Award 2
Breaking Medicine Technology:Suneva Medical Announces Corporate Developments Including Appointment of Philip Ranker as Chief Financial Officer 2Suneva Medical Announces Corporate Developments Including Appointment of Philip Ranker as Chief Financial Officer 3Suneva Medical Announces Corporate Developments Including Appointment of Philip Ranker as Chief Financial Officer 4AcceleDent Science is Showcased in New Continuing Education Course Published by PennWell 2AcceleDent Science is Showcased in New Continuing Education Course Published by PennWell 3AcceleDent Science is Showcased in New Continuing Education Course Published by PennWell 4Bayer 'Express Your Simple Win Creativity Contest' Grand Prize Winners Announced 2Bayer 'Express Your Simple Win Creativity Contest' Grand Prize Winners Announced 3NC State receives NSF grant to discover plant switchboards 9774 1NC State receives NSF grant to discover plant switchboards 9774 2NC State receives NSF grant to discover plant switchboards 9774 3Researchers design new graphene based nano material with magnetic properties 13810 1Researchers design new graphene based nano material with magnetic properties 13810 2Pew poll 3A 9 in 10 Iowa voters support more government oversight of food 56091 1Pew poll 3A 9 in 10 Iowa voters support more government oversight of food 56091 2
Other Medicine Technology:BARACLUDE(R) (Entecavir) Treatment Resulted In Greater Viral Load Suppression Compared to Adefovir at 96 Weeks In Antiviral-Naive Adult Chronic Hepatitis B E-Antigen Positive Patients 2BARACLUDE(R) (Entecavir) Treatment Resulted In Greater Viral Load Suppression Compared to Adefovir at 96 Weeks In Antiviral-Naive Adult Chronic Hepatitis B E-Antigen Positive Patients 3BARACLUDE(R) (Entecavir) Treatment Resulted In Greater Viral Load Suppression Compared to Adefovir at 96 Weeks In Antiviral-Naive Adult Chronic Hepatitis B E-Antigen Positive Patients 4BARACLUDE(R) (Entecavir) Treatment Resulted In Greater Viral Load Suppression Compared to Adefovir at 96 Weeks In Antiviral-Naive Adult Chronic Hepatitis B E-Antigen Positive Patients 5BARACLUDE(R) (Entecavir) Treatment Resulted In Greater Viral Load Suppression Compared to Adefovir at 96 Weeks In Antiviral-Naive Adult Chronic Hepatitis B E-Antigen Positive Patients 6BARACLUDE(R) (Entecavir) Treatment Resulted In Greater Viral Load Suppression Compared to Adefovir at 96 Weeks In Antiviral-Naive Adult Chronic Hepatitis B E-Antigen Positive Patients 7Pharmasset Presents Results of 4-Week Combination Study of R7128 for the Treatment of Chronic Hepatitis C 2Pharmasset Presents Results of 4-Week Combination Study of R7128 for the Treatment of Chronic Hepatitis C 3Pharmasset Presents Results of 4-Week Combination Study of R7128 for the Treatment of Chronic Hepatitis C 4Pharmasset Presents Results of 4-Week Combination Study of R7128 for the Treatment of Chronic Hepatitis C 5Pharmasset Presents Results of 4-Week Combination Study of R7128 for the Treatment of Chronic Hepatitis C 6